Antiva Biosciences

Using a novel new medicinal chemistry platform, HTI is focused on the development and commercialization of direct acting antivirals for infections with the human papilloma virus, human and animal retroviruses and herpes group viruses.

Focus area
Infectious Diseases & Vaccines
Commencement date
03/13/2013